Explore the vital role of community oncology in GU cancer treatment, bridging research and real-world applications for better patient care.
Manojkumar Bupathi, MD, MS
Advertisement
Manojkumar Bupathi, MD, MS, is medical oncologist at Rocky Mountain Cancer Centers. He specializes in solid tumors with an advanced subspecialty expertise in breast cancers and genitourinary cancers
Articles by Manojkumar Bupathi, MD, MS
Manojkumar Bupathi, MD, MS, discusses physician perspectives on treatment selection for frontline metastatic renal cell carcinoma (RCC) from a Case-Based Roundtable event.
Manojkumar Bupathi, MD, MS, discusses the updated efficacy results of the CheckMate 9ER trial of cabozantinib plus nivolumab for patients with previously untreated advanced clear cell renal cell carcinoma.
Advertisement
Latest Updated Articles
Supporting Community Oncologists in a GU Research EraPublished: January 21st 2026 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Daratumumab Quadruplet for Transplant-Ineligible Myeloma
2
Atebimetinib Combo Shows Compelling 1-Year OS in First-Line Pancreatic Cancer
3
FDA Grants Fast Track Designation to IBI3003 for R/R Multiple Myeloma
4
Tafasitamab Combo Significantly Extends PFS in R/R Follicular Lymphoma
5